glutathione depletion methylation cycle block Metabolism and epigenetics at the heart of T cell function: Trends in Immunology Folic acid modulates VPO1 DNA

The EMPA-REG and CANVAS trials showed that the SGLT-2i empagliflozin and SGLT-1/2i canagliflozin reduced the risk of MACE in T2D patients with or at high risk of CVD by 14%, while the SGLT-2i dapagliflozin did not significantly reduce the risk of MACE, possibly due to the difference in population (approximately 60% with no established ASCVD) between previous trials and strict exclusion criteria

Zinchuk VV, Pronko TP, Lis MA

160 Efficacy also was reported when combining heparin with lidocaine (40,000 IU heparin, 3 ml 8.4% sodium bicarbonate with 8 ml 1% or 2% lidocaine

Many Meraki patients use IV therapy to reduce inflammation, speed up recovery, and improve skin clarity before or after surgery